- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 22.08. | US insomniacs have a new prescription DTx option | ||
| 22.08. | BioMarin revamps leadership with ex-Roche, Amgen execs | ||
| 21.08. | Tony Blair: digital health records 'will prepare NHS for AI' | ||
| 21.08. | Study reignites debate on GLP-1 drugs and suicide risk | ||
| 21.08. | Medicare plans accuse Teva of covering copays for patients | ||
| 21.08. | J&J's Rybrevant okay challenges Tagrisso in first-line NSCLC | ||
| 20.08. | Lilly says tirzepatide staves off diabetes in phase 3 trial | ||
| 20.08. | Expert says supplies of mpox vaccine unlikely to suffice | ||
| 20.08. | Adcendo licenses Multitude anti-TF ADC in $1bn+ deal | ||
| 20.08. | Buoyed by muscular dystrophy data, Avidity raises $345m | ||
| 20.08. | GSK bags breakthrough status for B7-H3 ADC for lung cancer | ||
| 20.08. | US govt taps Walgreens for decentralised trials | ||
| 19.08. | NGOs plead for Gaza ceasefire for polio vaccinations | ||
| 19.08. | Kamala Harris vows to extend key health reforms to all in US | ||
| 19.08. | EU starts review of Enhertu in HER2-ultra-low breast cancer | ||
| 19.08. | EU starts review of Enhertu in HER2-ultralow breast cancer | ||
| 19.08. | Pfizer and BioNTech's COVID/flu vaccine hits a hurdle | ||
| 16.08. | Lykos co-founder Doblin to step down after MDMA setback | ||
| 16.08. | With FDA okay, AZ takes on MSD in early-stage lung cancer | ||
| 16.08. | As WHO calls mpox emergency, NIH says only drug ineffective | ||
| 16.08. | Biden, Harris 'just getting started' on IRA drug price cuts | ||
| 15.08. | IRA negotiated prices revealed as Biden claims $6bn savings | ||
| 15.08. | AI chatbots struggle to interpret patient descriptions | ||
| 15.08. | PBC drug choices rise in US with OK for Gilead's seladelpar | ||
| 15.08. | Incyte builds GvHD presence with Niktimvo approval |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
